Questo sito usa cookie per fornirti un'esperienza migliore. Proseguendo la navigazione accetti l'utilizzo dei cookie da parte nostra OK Approfondisci

Mediterranean Network for One Health (MEDNET 4OH)

Tunisia

Status

Implementation

Aid type

Project-type interventions

Tunisia


Location

-

€ 1,500,000
Committed
€ 600,000
Used

Description

MED-NET 4OH is a multidisciplinary project focused on "One Health" approach which intends to consolidate the positive results achieved as part of a previous intervention (MED-NET, 2022), financed by the WHO and entrusted to IZS as a technical partner. MED-NET 4OH will promote a scientific platform to address threats from emerging, re-emerging and endemic infectious diseases following the "One Health" approach (which recognizes the indissoluble link between human, animal and ecosystem health in the preparation of prevention plans for promptly address possible health threats) and foreseeing the improvement of genomic surveillance capabilities in Tunisia and the development of a digital platform for the real-time acquisition of genomic data of SARS-CoV-2 and other pathogens of possible impact for public health, obtained through Whole-Genome Sequencing (WGS). The initiative's main result is to develop genomic surveillance programs, the rapid identification and characterization of the etiological agent of infectious diseases and the collection, digitization and sharing of genomic data. The expected outputs will be obtained through a methodology that involves the use of digital technologies applicable to the monitoring and analysis of epidemics, the tracking, prevention, control and treatment of viruses and the use of human and financial resources, the sharing of collected data, strengthening of skills in order to improve capabilities in genomic/metagenomic sequencing and bioinformatics analysis, promotion of regional cooperation in the Mediterranean area on pandemic and epidemic countermeasures. The initiative intends to carry out and apply an upgrade in whole genome sequencing techniques and methods with the aim of evaluating the genetic diversity and transmission dynamics of human respiratory syncytial virus, arboviruses and SARS-CoV-2, and to evaluate the presence of antibiotic-resistant pathogens even outside the hospital environment, in the animal health sector, food and in the environment (for example, in wastewater). In particular, the integration between the MEDNET platform and the SORMAS system currently in use is envisaged in order to implement the best interoperability mechanism that allows data sharing between the two systems. MEDNET 40H also intends to conduct specific studies on priority zoonotic diseases present in Tunisia (e.g. tuberculosis) to implement control strategies to reduce the burden and impact of these diseases on public health. The target groups identified are 75 healthcare and informatic workers from the following hospitals and public health institutes: Pasteur Institute of Tunis; Charles Nicolle Hospital in Tunis; National Observatory of New and Emerging Diseases of Tunis, and 5 scientific communicators. The project will be implemented for a period of 3 years starting from April 2024 with a total budget of 1,621,799.00 euros. To ensure timely and effective implementation of the project, a multi-sectoral team of experts will be mobilized, establishing collaborations with international, national and subnational partners for regional innovation in preventive health care. read more close
Year Committed Used
2024 € 1,500,000 € 600,000

Agency

Type Name Channel code
Government AICS - Italian Agency for Cooperation and Development 11000

Channel reported

Type Name Channel code
Other Public Sector ISTITUTO ZOOPROFILATTICO SPERIMENTALE ABRUZZO E MOLISE GIUSEPPE 11004

Project data

  • IATI IdentifierXM-DAC-6-4-013054-01-0
  • AID013054/01/0
  • CRS Activity identifier2024040238
  • Planned start 2024/06/03
  • Planned End 2027/06/02
  • Actual start 2024/09/20
  • Actual end -
  • Bi/Multilateral Bilateral
  • Status Implementation
  • Tied status Untied

Sectors

  • 12220 - Basic health care 100.0%

Policy markers

  • Gender Equality not targeted
  • Disaster Risk Reduction(DRR) not targeted
  • Disability not targeted
  • Nutrition not targeted
  • Aid to Environment significant objective
  • Participatory Development/Good Governance principal objective
  • Trade Development not targeted
  • Aid Targeting the Objectives of the Convention on Biological Diversity not targeted
  • Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation not targeted
  • Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation significant objective
  • Aid Targeting the Objectives of the Convention to Combat Desertification not targeted
  • Reproductive, Maternal, Newborn and Child Health (RMNCH) not targeted

SDGs

  • 17.6 - Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge-sharing on mutually agreed terms, including through improved coordination among existing mechanisms, in particular at the United Nations level, and through a global technology facilitation mechanism
  • 17.7 - Promote the development, transfer, dissemination and diffusion of environmentally sound technologies to developing countries on favourable terms, including on concessional and preferential terms, as mutually agreed
  • 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
  • 3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks
  • 9.5 - Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and development workers per 1 million people and public and private research and development spending
-
-
-